These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 29643358

  • 1. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.
    Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Sweeney JA, McCarroll SA, Robinson EB.
    Transl Psychiatry; 2018 Apr 12; 8(1):78. PubMed ID: 29643358
    [Abstract] [Full Text] [Related]

  • 2. Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.
    Nicodemus KK, Hargreaves A, Morris D, Anney R, Schizophrenia Psychiatric Genome-wide Association Study (GWAS) Consortium, Wellcome Trust Case Control Consortium 2, Gill M, Corvin A, Donohoe G.
    JAMA Psychiatry; 2014 Jul 01; 71(7):778-785. PubMed ID: 24828433
    [Abstract] [Full Text] [Related]

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 01; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 4. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.
    Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA.
    Schizophr Res; 2015 Aug 01; 166(1-3):310-5. PubMed ID: 26008884
    [Abstract] [Full Text] [Related]

  • 5. A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains.
    Ranlund S, Calafato S, Thygesen JH, Lin K, Cahn W, Crespo-Facorro B, de Zwarte SMC, Díez Á, Di Forti M, GROUP, Iyegbe C, Jablensky A, Jones R, Hall MH, Kahn R, Kalaydjieva L, Kravariti E, McDonald C, McIntosh AM, McQuillin A, PEIC, Picchioni M, Prata DP, Rujescu D, Schulze K, Shaikh M, Toulopoulou T, van Haren N, van Os J, Vassos E, Walshe M, WTCCC2, Lewis C, Murray RM, Powell J, Bramon E.
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan 01; 177(1):21-34. PubMed ID: 28851104
    [Abstract] [Full Text] [Related]

  • 6. Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.
    Hochberger WC, Hill SK, Nelson CL, Reilly JL, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Sweeney JA.
    Schizophr Res; 2016 Jan 01; 170(1):156-61. PubMed ID: 26645510
    [Abstract] [Full Text] [Related]

  • 7. Polygenic risk for schizophrenia predicting social trajectories in a general population sample.
    Saarinen A, Hietala J, Lyytikäinen LP, Hamal Mishra B, Sormunen E, Lavonius V, Kähönen M, Raitakari O, Lehtimäki T, Keltikangas-Järvinen L.
    Psychol Med; 2024 Jun 01; 54(8):1589-1597. PubMed ID: 38047377
    [Abstract] [Full Text] [Related]

  • 8. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.
    van Os J, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC, Genetic Risk and Outcome Investigators (GROUP), Arango C, O'Donovan M, Rutten BPF, Guloksuz S.
    Psychol Med; 2020 Aug 01; 50(11):1884-1897. PubMed ID: 31414981
    [Abstract] [Full Text] [Related]

  • 9. Polygenic scores for schizophrenia and general cognitive ability: associations with six cognitive domains, premorbid intelligence, and cognitive composite score in individuals with a psychotic disorder and in healthy controls.
    Engen MJ, Lyngstad SH, Ueland T, Simonsen CE, Vaskinn A, Smeland O, Bettella F, Lagerberg TV, Djurovic S, Andreassen OA, Melle I.
    Transl Psychiatry; 2020 Nov 30; 10(1):416. PubMed ID: 33257657
    [Abstract] [Full Text] [Related]

  • 10. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age.
    Türközer HB, Ivleva EI, Palka J, Clementz BA, Shafee R, Pearlson GD, Sweeney JA, Keshavan MS, Gershon ES, Tamminga CA.
    Schizophr Bull; 2021 Jul 08; 47(4):1058-1067. PubMed ID: 33693883
    [Abstract] [Full Text] [Related]

  • 11. Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Wang MY, Ho NF, Sum MY, Collinson SL, Sim K.
    Schizophr Res; 2016 Aug 08; 175(1-3):97-102. PubMed ID: 27146474
    [Abstract] [Full Text] [Related]

  • 12. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.
    Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, Tooney PA, Scott RJ, Carr VJ, Australian Schizophrenia Research Bank.
    Mol Psychiatry; 2013 Jul 08; 18(7):774-80. PubMed ID: 22733126
    [Abstract] [Full Text] [Related]

  • 13. Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition.
    Sheffield JM, Kandala S, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA, Clementz BA, Lerman-Sinkoff DB, Hill SK, Barch DM.
    JAMA Psychiatry; 2017 Jun 01; 74(6):605-613. PubMed ID: 28467520
    [Abstract] [Full Text] [Related]

  • 14. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.
    Calafato MS, Thygesen JH, Ranlund S, Zartaloudi E, Cahn W, Crespo-Facorro B, Díez-Revuelta Á, Di Forti M, Genetic Risk and Outcome of Psychosis (GROUP) consortium, Hall MH, Iyegbe C, Jablensky A, Kahn R, Kalaydjieva L, Kravariti E, Lin K, McDonald C, McIntosh AM, McQuillin A, Picchioni M, Rujescu D, Shaikh M, Toulopoulou T, Os JV, Vassos E, Walshe M, Powell J, Lewis CM, Murray RM, Bramon E.
    Br J Psychiatry; 2018 Sep 01; 213(3):535-541. PubMed ID: 30113282
    [Abstract] [Full Text] [Related]

  • 15. The one and the many: effects of the cell adhesion molecule pathway on neuropsychological function in psychosis.
    Hargreaves A, Anney R, O'Dushlaine C, Nicodemus KK, Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ), Wellcome Trust Case Control Consortium 2, Gill M, Corvin A, Morris D, Donohoe G.
    Psychol Med; 2014 Jul 01; 44(10):2177-87. PubMed ID: 24284030
    [Abstract] [Full Text] [Related]

  • 16. Association between polygenic risk for schizophrenia, neurocognition and social cognition across development.
    Germine L, Robinson EB, Smoller JW, Calkins ME, Moore TM, Hakonarson H, Daly MJ, Lee PH, Holmes AJ, Buckner RL, Gur RC, Gur RE.
    Transl Psychiatry; 2016 Oct 18; 6(10):e924. PubMed ID: 27754483
    [Abstract] [Full Text] [Related]

  • 17. Deviation from expected cognitive ability across psychotic disorders.
    Hochberger WC, Combs T, Reilly JL, Bishop JR, Keefe RSE, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA, Hill SK, Sweeney JA.
    Schizophr Res; 2018 Feb 18; 192():300-307. PubMed ID: 28545944
    [Abstract] [Full Text] [Related]

  • 18. Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use.
    Hanna RC, Shalvoy A, Cullum CM, Ivleva EI, Keshavan M, Pearlson G, Hill SK, Sweeney JA, Tamminga CA, Ghose S.
    Schizophr Bull; 2016 Nov 18; 42(6):1496-1503. PubMed ID: 27033329
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    DeMichele-Sweet MAA, Weamer EA, Klei L, Vrana DT, Hollingshead DJ, Seltman HJ, Sims R, Foroud T, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Ruiz A, Williams J, Mayeux R, Lopez OL, Sibille EL, Kamboh MI, Devlin B, Sweet RA.
    Mol Psychiatry; 2018 Apr 18; 23(4):963-972. PubMed ID: 28461698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.